Executive Summary
Cytognosis Foundation is developing AI-native healthcare technologies that detect and prevent disease before symptoms emerge. Our data strategy focuses on creating a comprehensive, ethical, and globally accessible framework for multimodal health data integration while maintaining the highest standards of privacy, security, and regulatory compliance.
Vision & Mission
Vision
A world where preventive healthcare is accessible to all through AI-driven early detection and intervention, supported by diverse, representative, and ethically managed health datasets.
Mission
To develop and maintain a world-class data infrastructure that enables breakthrough AI research in preventive healthcare while ensuring privacy, equity, and global accessibility.
Strategic Objectives
1. Multimodal Data Integration
Objective: Create unified datasets combining genomics, proteomics, imaging, clinical, and behavioral data.
Key Initiatives:
Develop standardized data collection protocols across modalities
Implement FHIR-compliant data models for interoperability
Create AI-optimized data structures for machine learning
Establish quality assurance frameworks for data validation
2. Privacy-Preserving AI Development
Objective: Advance AI research while maintaining strict privacy protections and regulatory compliance.
Key Initiatives:
Implement federated learning architectures
Develop differential privacy techniques for health data
Create secure multi-party computation frameworks
Establish privacy-preserving synthetic data generation
3. Global Health Equity
Objective: Ensure datasets represent diverse populations and address global health disparities.
Key Initiatives:
Partner with healthcare systems in underserved regions
Develop culturally sensitive data collection protocols
Create bias detection and mitigation frameworks
Establish equitable data sharing agreements
4. Open Science & Collaboration
Objective: Accelerate global health research through responsible data sharing and collaboration.
The FAIRification Process & Principles
Cytognosis Foundation legally mandates that all public and controlled-access datasets undergo a rigorous FAIRification Process prior to distribution. Data is useless if it cannot be discovered or understood by machines and external researchers.
Every dataset must satisfy the 15 FAIR Guiding Principles (Wilkinson et al., 2016):
1. Findable
F1: (Meta)data are assigned a globally unique and persistent identifier (PID).
F2: Data are described with rich metadata.
F3: Metadata clearly and explicitly include the identifier of the data they describe.
F4: (Meta)data are registered or indexed in a searchable resource.
2. Accessible
A1: (Meta)data are retrievable by their identifier using a standardized communications protocol.
-
A1.1: The protocol is open, free, and universally implementable.
-
A1.2: The protocol allows for an authentication and authorization procedure, where necessary (critical for HIPAA/PHI data).
A2: Metadata are accessible, even when the data are no longer available.
3. Interoperable
I1: (Meta)data use a formal, accessible, shared, and broadly applicable language for knowledge representation.
I2: (Meta)data use vocabularies that follow FAIR principles (e.g., standard biomedical ontologies).
I3: (Meta)data include qualified references to other (meta)data.
4. Reusable
R1: (Meta)data are richly described with a plurality of accurate and relevant attributes.
-
R1.1: (Meta)data are released with a clear and accessible data usage license.
-
R1.2: (Meta)data are associated with detailed provenance.
-
R1.3: (Meta)data meet domain-relevant community standards.
Public Dataset Portfolio (2025-2030)
1. Cytognosis Multimodal Prevention Dataset (CMPD)
Description: De-identified multimodal health data for early disease detection research
Data Types: Genomic variants, proteomic biomarkers, imaging, clinical labs, lifestyle factors.
Access: Open access with data use agreement
2. Global Health Disparities Dataset (GHDD)
Description: Comprehensive dataset addressing health disparities across populations
Data Types: Social determinants, access metrics, population outcomes.
Access: Open access with attribution requirement
3. AI-Ready Preventive Care Dataset (ARPCD)
Description: Longitudinal dataset optimized for AI/ML model development
Access: Controlled access with research proposal review
4. Federated Learning Benchmark Dataset (FLBD)
Description: Standardized datasets for federated learning research in healthcare
Access: Open access with technical requirements
5. Cytognosis Synthetic Health Dataset (CSHD)
Description: High-fidelity synthetic health data for unrestricted research use
Access: Completely open with no restrictions
Privacy-Preserving Technologies
De-identification Framework
Safe Harbor Method: Remove 18 HIPAA identifiers
Expert Determination: Statistical disclosure control
K-anonymity: Minimum group size requirements (k≥5)
L-diversity: Sensitive attribute diversity
T-closeness: Distribution similarity constraints
Advanced Privacy Techniques
Differential Privacy: Formal privacy guarantees with ε-δ privacy
Homomorphic Encryption: Computation on encrypted data
Secure Multi-party Computation: Collaborative analysis without sharing
Federated Learning: Model training without centralized data
Data Governance Framework
Governance Structure
``text
Data Governance Committee
├── Chief Data Officer (CDO)
├── Privacy Officer
├── Compliance Officer
├── Research Director
└── External Advisory Board
├── Medical Ethics Expert
├── Privacy & Security Specialist
├── Regulatory Affairs Professional
└── Patient Advocacy Representative
`
Access Control Models
1. Open Access: No registration, attribution required only.
2. Controlled Access: Research proposal required, DUA execution, institutional affiliation.
3. Federated Access: On-site analysis only, algorithms vetted prior to execution.
Technical Architecture
Data Infrastructure
`
text
Data Lake (Encrypted)
├── Raw Data Ingestion
│ ├── Multi-omics Pipeline
│ └── Clinical Data Pipeline
├── Data Processing & Validation
│ ├── Quality Assurance
│ ├── Standardization
│ └── De-identification
├── Federated Learning Platform
│ └── Privacy Preservation Platform
└── Data Distribution Layer
`
Security & Privacy Controls
Encryption: AES-256 at rest, TLS 1.3 in transit
Access Control: Role-based with multi-factor authentication
Audit Logging: Comprehensive access and modification logs
Data Minimization: Purpose-limited collection and processing
Regulatory Compliance Ecosystem
HIPAA Compliance (US)
Administrative Safeguards: Policies, training, BAAs, incident response
Technical Safeguards: Access controls, encryption, audit logs
GDPR Compliance (EU)
Lawful Basis: Consent, scientific research exemptions
Data Subject Rights: Automated handling for erasure & access
FDA Guidelines
Software as Medical Device (SaMD): Risk-based classification
Clinical Validation: Analytical/clinical performance audits
International Partnerships & Collaborations
Academic: Harvard T.H. Chan, Oxford Big Data Institute, MIT CSAIL
Health Systems: Partners HealthCare, NHS Digital, UK Biobank
Global Data Orgs: WHO, EMA, FAIR principles alignment
Operational layers (cross-references)
The strategy above is implemented through these documents in this directory:
public-data-strategy.md
— public dataset roadmap, privacy-preserving release, partnerships.
dataset-catalog.md
— stratification of multimodal datasets by access tier and infrastructure requirements.
TECHNICAL_DATA_INFRASTRUCTURE.md
— GCP project boundaries, GCS bucket taxonomy, VPC-SC, Healthcare API.
paper-library-architecture.md
— sovereign library (Drive + Zotero metadata-only + Hypothes.is + future Neo4j).
scholarly-knowledge-graph.md
— LinkML schema spanning bibliographic, scholarly, biomedical, and artifact entities.
sssom-cross-ontology-mapping.md
— UMLS / MONDO / HP / CL / CHEBI / NCBITaxon / SNOMED CT mapping stack.
monday-resource-boards.md
— Resources workspace as the human-resolution KG until Neo4j is fully online.
linkml-kg-playbook.md
— pointer to the 22-chapter hands-on playbook.
compliance/hipaa-compliance-framework.md
and the PHI checklist — HIPAA program.
policies/data-governance-policy.md
, policies/controlled-data-access.md
, policies/nih-nda-access-procedures.md
— governance and acquisition SOPs.
schemas/multimodal-health-data-schema.md
— JSON schemas for the multimodal patient record.
templates/data-use-agreement-template.md` — outbound DUA template.
Document Version: 2.1
Last Updated: May 2026
Next Review: November 2026
Owner: Chief Data Officer, Cytognosis Foundation